128 related articles for article (PubMed ID: 9698050)
1. Human urinary trypsin inhibitor inhibits the activation of pro-matrix metalloproteinases and proteoglycans release in rabbit articular cartilage.
Hashimoto K; Nagao Y; Kato K; Mori Y; Ito A
Life Sci; 1998; 63(3):205-13. PubMed ID: 9698050
[TBL] [Abstract][Full Text] [Related]
2. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
3. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha.
Lefebvre V; Peeters-Joris C; Vaes G
Biochim Biophys Acta; 1991 Aug; 1094(1):8-18. PubMed ID: 1653026
[TBL] [Abstract][Full Text] [Related]
4. Collagen degradation induced by the combination of IL-1alpha and plasminogen in rabbit articular cartilage explant culture.
Saito S; Katoh M; Masumoto M; Matsumoto S; Masuho Y
J Biochem; 1997 Jul; 122(1):49-54. PubMed ID: 9276670
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes.
Ito A; Nose T; Takahashi S; Mori Y
FEBS Lett; 1995 Feb; 360(1):75-9. PubMed ID: 7875305
[TBL] [Abstract][Full Text] [Related]
6. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
7. Urinary trypsin inhibitor suppresses the production of interstitial procollagenase/proMMP-1 and prostromelysin 1/proMMP-3 in human uterine cervical fibroblasts and chorionic cells.
Imada K; Ito A; Kanayama N; Terao T; Mori Y
FEBS Lett; 1997 Nov; 417(3):337-40. PubMed ID: 9409746
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes.
Sasaki K; Hattori T; Fujisawa T; Takahashi K; Inoue H; Takigawa M
J Biochem; 1998 Mar; 123(3):431-9. PubMed ID: 9538225
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
10. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
11. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinase production by rabbit articular cartilage: comparison of the effects of interleukin-1 alpha in vitro and in vivo.
Hembry RM; Bagga MR; Dingle JT; Thomas PP; Reynolds JJ
Virchows Arch; 1994; 425(4):413-24. PubMed ID: 7529620
[TBL] [Abstract][Full Text] [Related]
14. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases.
Hahn-Dantona E; Ramos-DeSimone N; Sipley J; Nagase H; French DL; Quigley JP
Ann N Y Acad Sci; 1999 Jun; 878():372-87. PubMed ID: 10415742
[TBL] [Abstract][Full Text] [Related]
15. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
Stanton H; Ung L; Fosang AJ
Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
[TBL] [Abstract][Full Text] [Related]
17. Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases.
Hao JL; Nagano T; Nakamura M; Kumagai N; Mishima H; Nishida T
Exp Eye Res; 1999 May; 68(5):565-72. PubMed ID: 10328970
[TBL] [Abstract][Full Text] [Related]
18. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 beta and a protein kinase C activator.
Ogata Y; Pratta MA; Nagase H; Arner EC
Exp Cell Res; 1992 Aug; 201(2):245-9. PubMed ID: 1322311
[TBL] [Abstract][Full Text] [Related]
20. Effect of Betula platyphylla var. japonica on proteoglycan release, type II collagen degradation, and matrix metalloproteinase expression in rabbit articular cartilage explants.
Cho YJ; Huh JE; Kim DY; Kim NJ; Lee JD; Baek YH; Cho EM; Yang HR; Choi DY; Park DS
Biol Pharm Bull; 2006 Jul; 29(7):1408-13. PubMed ID: 16819179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
